BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19864035)

  • 1. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
    Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
    J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma.
    Okusaka T; Okada S; Ueno H; Ikeda M; Iwata R; Furukawa H; Takayasu K; Moriyama N; Sato T; Sato K
    Oncology; 2002; 62(3):228-33. PubMed ID: 12065870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
    Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma].
    Matoba M; Okimura T; Yamamoto I
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial infusion chemotherapy with SMANCS].
    Nekohashi T; Maruno J; Sanjou A; Toda G
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025
    [No Abstract]   [Full Text] [Related]  

  • 10. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI].
    Shimizu T; Endou H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma].
    Suzuki M; Fukuhara K; Unno M; Endoh K; Takeuchi H; Kodama H; Oikawa M; Matsuno S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881].
    Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1665-75. PubMed ID: 1714707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
    Sohara N; Takagi H; Abe T; Hashimoto Y; Kojima A; Takahashi H; Nagamine T; Mori M
    Support Care Cancer; 1999 Mar; 7(2):84-8. PubMed ID: 10089088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficiency of segmental SMANCS/Lip-TAE for hepatocellular carcinoma--comparative studies in the efficacy of segmental SMANCS/Lip-TAI].
    Matoba M; Mitsuya T; Ichiyanagi K; Morita M; Kidani E; Ibe N; Tatsumi Y; Tamamura H; Nakagawa T; Okimura T; Yamamoto I
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):37-42. PubMed ID: 9020943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
    Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
    Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma].
    Numata K; Tanaka K; Kiba T; Saito S; Morita K; Kitamura T; Kondo M; Morimoto M; Shirato K; Hori A; Shimamura T; Isozaki T; Arata S; Okazaki H; Fujii T; Sekihara H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():141-5. PubMed ID: 9512702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma].
    Inoue Y; Tomoda K; Oi H; Nakamura H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.